Search - tctmd.com

Displaying 381 - 400 of 800

Sort: Relevancy | Date

News Daily News

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

L.A. McKeown

March 14, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

News Daily News

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Shelley Wood

February 24, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

News Industry News

Micro Medical Solutions Receives CE Mark Approval for MicroStent

February 14, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Features

Trump’s Immigration Order Quickly Hits Home for Some Foreign-Born Physicians

Todd Neale

January 31, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Daily News

Obama Signs 21st Century Cures Act Into Law

Caitlin E. Cox

December 15, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Daily News

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

Todd Neale

November 09, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2016

Ankur Kalra

October 27, 2016

News Daily News

Minnesota’s Device Companies Pumping Money into Congressional Race to Re-Elect Their Champion

Michael O'Riordan

October 12, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

L.A. McKeown

September 22, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

Advertisement

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Four-in-One Blood Pressure Pill Shows Promise as Initial Therapy

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Micro Medical Solutions Receives CE Mark Approval for MicroStent

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Trump’s Immigration Order Quickly Hits Home for Some Foreign-Born Physicians

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Obama Signs 21st Century Cures Act Into Law

TCTMD’s Top 10 Most Popular Stories for November 2016

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

My Picks for Fellows Attending TCT 2016

Minnesota’s Device Companies Pumping Money into Congressional Race to Re-Elect Their Champion

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

TCTMD’s Top 10 Most Popular Stories for August 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content